Stay updated on Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T23:51:30.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on advanced breast cancer, while adding a new revision number and an EudraCT number.
    Difference
    13%
    Check dated 2025-04-17T11:03:54.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 13, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.
    Difference
    0.2%
    Check dated 2025-04-10T05:33:51.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    72 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.6%
    Check dated 2025-02-25T19:12:19.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed information about a clinical study evaluating the efficacy and safety of alpelisib plus fulvestrant in treating advanced breast cancer, with specific focus on patient eligibility criteria and treatment protocols. Additionally, several clinical sites and locations have been added or modified.
    Difference
    79%
    Check dated 2025-02-18T09:45:31.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.8%
    Check dated 2025-02-11T07:35:18.000Z thumbnail image

Stay in the know with updates to Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.